Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$94,949,960
+$7,518,665 QoQ
Shares Held
2,212,770
+1.8% QoQ
Ownership
3.07%
of shares outstanding
% of Portfolio
5.18%
of 13F equity value
Holder Rank
#12
of 217 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. VERA ranks #2 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
913,880 | $121,783,648 | |
| 2 | VERA |
Vera Therapeutics, Inc.
This page
|
2,212,770 | $94,949,960 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
1,785,941 | $66,454,864 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
2,798,210 | $61,168,870 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
664,684 | $52,702,794 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
798,973 | $45,389,656 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
629,952 | $36,619,109 | |
| 8 | GERN |
Geron Corp
|
18,717,422 | $23,958,300 |
All Filings in VERA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,949,960 | 2,212,770 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $87,431,295 | 2,173,286 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $155,581,474 | 3,072,304 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $81,595,714 | 2,807,836 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $56,144,775 | 2,383,055 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $45,609,272 | 1,898,804 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $67,664,634 | 1,600,015 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $90,616,939 | 2,050,157 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $73,923,482 | 2,043,214 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $78,641,436 | 1,823,781 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,450,085 | 1,914,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,270,084 | 1,478,489 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $27,942,263 | 1,740,951 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $13,878,985 | 1,788,529 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $7,958,809 | 411,308 | Shares | Sole | 2023-11-08 | |
| 2022-09-30 | $3,327,108 | 156,129 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||